Kailera Therapeutics, Inc. (KLRA)
11.99
-0.84
(-6.55%)
USD |
NASDAQ |
Sep 21, 16:00
12.16
+0.17
(+1.42%)
After-Hours: 20:00
Kailera Therapeutics Net Income (Quarterly) : -111.31M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -111.31M |
| March 31, 2026 | -78.86M |
| Date | Value |
|---|---|
| June 30, 2025 | -28.95M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Oncolytics Biotech, Inc. | -9.442M |
| Sangamo Therapeutics, Inc. | -31.00M |
| Sarepta Therapeutics, Inc. | -4.89M |
| Anixa Biosciences, Inc. | -2.625M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 111.31M |
| EPS Diluted (Quarterly) | -0.8587 |
| Enterprise Value | 647.62M |
| Earnings Yield | -14.10% |